140 filings
Page 7 of 7
8-K
06rnuk0c
2 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
a86ohq lx
18 Nov 14
Arch Therapeutics Reports Positive Preclinical Data from Study of AC5
12:00am
8-K
mekm2alq2
6 Nov 14
Other Events
12:00am
8-K
x58lsye1o
8 Sep 14
Arch Therapeutics Announces Positive Preclinical Data from an Independent Study of AC5 Surgical Hemostatic Device™ in Animals on Blood Thinners
12:00am
8-K
dtq7m28t426v sfdr6i
25 Aug 14
Arch Therapeutics Announces Positive Preclinical Data from its Study of AC5 Surgical Hemostatic Device™ in Animals on Blood Thinner
12:00am
8-K
r35s7zgobjpwxdl8
6 Aug 14
Arch Therapeutics Announces Third Quarter 2014 Results
12:00am
8-K
4iu0qjzztqhy3bm
7 Jul 14
Arch Therapeutics Appoints Richard Davis as Chief Financial Officer
12:00am
8-K
6eux5l 64
1 May 14
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
a2ams5nhssbd4 jqx
27 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
iyosa
10 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
avqtgh7s
31 Jan 14
Arch Therapeutics Announces $2.85 Million Private Placement
12:00am
8-K
s2x467 byfurxlc9o
4 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
h52raefa6 znxan
8 Jul 13
Arch Therapeutics Appoints Senior Management Team Members
12:00am
8-K
jigyc
26 Jun 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
bomcalts
24 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
eh3tv mesbf1
5 Jun 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
tm86 njj8td31vhgre
24 May 13
Other Events
12:00am
8-K
byxsq0
13 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
toxym19c 17n
29 Apr 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
yg2mpf69ll6srtxszr78
25 Apr 13
Entry into a Material Definitive Agreement
12:00am